Literature DB >> 12061893

New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.

Fabienne Foufelle1, Pascal Ferré.   

Abstract

The regulation of hepatic glucose metabolism has a key role in whole-body energy metabolism, since the liver is able to store (glycogen synthesis, lipogenesis) and to produce (glycogenolysis, gluconeogenesis) glucose. These pathways are regulated at several levels, including a transcriptional level, since many of the metabolism-related genes are expressed according to the quantity and quality of nutrients. Recent advances have been made in the understanding of the regulation of hepatic glycolytic, lipogenic and gluconeogenic gene expression by pancreatic hormones, insulin and glucagon and glucose. Here we review the role of the transcription factors forkhead and sterol regulatory element binding protein-1c in the inductive and repressive effects of insulin on hepatic gene expression, and the pathway that leads from glucose to gene regulation with the recently discovered carbohydrate response element binding protein. We discuss how these transcription factors are integrated in a regulatory network that allows a fine tuning of hepatic glucose storage or production, and their potential importance in metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061893      PMCID: PMC1222807          DOI: 10.1042/BJ20020430

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  177 in total

Review 1.  Glucose and cAMP: adversaries in the regulation of hepatic gene expression.

Authors:  H C Towle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription.

Authors:  K Chakravarty; P Leahy; D Becard; P Hakimi; M Foretz; P Ferre; F Foufelle; R W Hanson
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

3.  Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences.

Authors:  D Yeagley; S Guo; T Unterman; P G Quinn
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

4.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.

Authors:  J Nakae; T Kitamura; D L Silver; D Accili
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein.

Authors:  T Kawaguchi; M Takenoshita; T Kabashima; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

6.  Spot 14 gene deletion increases hepatic de novo lipogenesis.

Authors:  Q Zhu; A Mariash; M R Margosian; S Gopinath; M T Fareed; G W Anderson; C N Mariash
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

7.  Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver.

Authors:  K Tobe; R Suzuki; M Aoyama; T Yamauchi; J Kamon; N Kubota; Y Terauchi; J Matsui; Y Akanuma; S Kimura; J Tanaka; M Abe; J Ohsumi; R Nagai; T Kadowaki
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

8.  Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice.

Authors:  D Bécard; I Hainault; D Azzout-Marniche; L Bertry-Coussot; P Ferré; F Foufelle
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

9.  Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats.

Authors:  R H Bandsma; C H Wiegman; A W Herling; H J Burger; A ter Harmsel; A J Meijer; J A Romijn; D J Reijngoud; F Kuipers
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

10.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more
  112 in total

1.  Anthocyanins inhibit lipogenesis during adipocyte differentiation of 3T3-L1 preadipocytes.

Authors:  Bonggi Lee; Minsup Lee; Michael Lefevre; Hyeung-Rak Kim
Journal:  Plant Foods Hum Nutr       Date:  2014-06       Impact factor: 3.921

2.  Adaptation of enterocytic Caco-2 cells to glucose modulates triacylglycerol-rich lipoprotein secretion through triacylglycerol targeting into the endoplasmic reticulum lumen.

Authors:  Thomas Pauquai; Julien Bouchoux; Danielle Chateau; Romain Vidal; Monique Rousset; Jean Chambaz; Sylvie Demignot
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 3.  Signalling mechanisms linking hepatic glucose and lipid metabolism.

Authors:  M O Weickert; A F H Pfeiffer
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

4.  Phospholipid homeostasis and lipotoxic cardiomyopathy: a matter of balance.

Authors:  Hui-Ying Lim; Rolf Bodmer
Journal:  Fly (Austin)       Date:  2011-07-01       Impact factor: 2.160

5.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 6.  Modulation of hepatic steatosis by dietary fatty acids.

Authors:  Alessandra Ferramosca; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 7.  Insulin regulation of gluconeogenesis.

Authors:  Maximilian Hatting; Clint D J Tavares; Kfir Sharabi; Amy K Rines; Pere Puigserver
Journal:  Ann N Y Acad Sci       Date:  2017-09-03       Impact factor: 5.691

8.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression.

Authors:  Yun Sok Lee; Dong Hyun Sohn; Daehee Han; Han-Woong Lee; Rho Hyun Seong; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

10.  Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.

Authors:  Lauren M Aleksunes; Scott A Reisman; Ronnie L Yeager; Michael J Goedken; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2010-01-19       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.